Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class ASSE: 603707

"Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd."Announcement on Subsidiary's Receipt of U.S. FDA Approval for an Additional Manufacturing Site for Amikacin Sulfate Injection

· Issued by Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Subsidiary's Receipt of U.S. FDA Approval for an Additional Manufacturing Site for Amikacin Sulfate Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A

All Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A news releases